Kassama v. Magat

767 A.2d 348, 136 Md. App. 637, 2001 Md. App. LEXIS 24
CourtCourt of Special Appeals of Maryland
DecidedFebruary 28, 2001
Docket837, Sept. Term, 1999
StatusPublished
Cited by11 cases

This text of 767 A.2d 348 (Kassama v. Magat) is published on Counsel Stack Legal Research, covering Court of Special Appeals of Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kassama v. Magat, 767 A.2d 348, 136 Md. App. 637, 2001 Md. App. LEXIS 24 (Md. Ct. App. 2001).

Opinion

SALMON, Judge.

In this “wrongful life” case, an infant plaintiff asserts that she would have been better off if she had never been born and that she should have been aborted. This presents a question of first impression in Maryland, viz:

May a doctor whose negligence caused a mother not to abort her pregnancy be successfully sued for “wrongful life” by a genetically defective child born as a consequence of the doctor’s negligence?

We hold that Maryland does not recognize a cause of action for wrongful life and, accordingly, answer that question in the negative.

Other issues that arose out of a companion “wrongful birth” claim must also be decided. 1

*642 I. PROCEDURAL AND FACTUAL BACKGROUND

On September 19, 1995, a daughter, Ibrion Fatuo Kassama, was born to Millicent Kassama. The delivery was uneventful; unfortunately, however, Ibrion was born with Down’s Syndrome. 2 During her pregnancy, Mrs. Kassama was treated by Dr. Aaron H. Magat, a board-certified obstetrician and gynecologist.

Mrs. Kassama, individually and on behalf of Ibrion, filed suit in the Circuit Court for Baltimore County against Dr. Magat, his professional association, and one of his associates. 3 The complaint contained counts for negligence and lack of informed consent. Mrs. Kassama alleged, inter alia, that, but for Dr. Magat’s negligence, she would have had an abortion and would not have delivered Ibrion (hereinafter “the wrongful-birth claim”). In her wrongful-birth claim, Mrs. Kassama, individually, claimed economic damages caused by the necessity of raising her genetically defective child.

*643 On behalf of Ibrion, Mrs. Kassama filed a claim for wrongful life based on negligence and lack of informed consent theories. Prior to trial, the court granted the defendants’ motion for partial summary judgment as to Ibrion’s claim of lack of informed consent.

The case was tried before a jury in the Circuit Court for Baltimore County. At the close of the plaintiffs case, the trial court granted the defendants’ motion for judgment as to Ibrion’s claim of negligence, as well as Mrs. Kassama’s lack of informed consent claim. 4 Thus, only Mrs. Kassama’s wrongful-birth claim was considered by the jury.

The jury found that Dr. Magat had breached the applicable standard of care and that the breach was a proximate cause of Mrs. Kassama’s injury. The jury also found that Mrs. Kassama was contributorily negligent and that her negligence was a proximate cause of her own injury.

After the trial judge considered and denied Mrs. Kassama’s motion for judgment notwithstanding the verdict, and motion for new trial, a timely appeal was filed by Mrs. Kassama, individually and on behalf of Ibrion. The defendants responded by filing a conditional cross-appeal.

II. QUESTIONS PRESENTED

Several of the questions raised by Mrs. Kassama deal with damages and need not be decided. 5 The questions that must be resolved are:

*644 1. Did the trial court err in allowing the jury to consider the issue of whether Mrs. Kassama was contributorily negligent?
2. Assuming that the answer to Question No. 1 is “no,” did the trial court err in failing to give the jury a last clear chance instruction?
3. Did the trial court err in granting Dr. Magat’s motion for judgment in regard to Ibrion’s wrongful-life claim?

We answer all three questions in the negative. Because we shall affirm the judgment entered in favor of the defendants, it is unnecessary to decide the issues raised in the cross-appeal. 6

III. MEDICAL BACKGROUND

An alpha fetoprotein (“AFP”) blood test is used to detect genetic defects. Ideally, the blood sample for the AFP test is drawn when a woman is fifteen to sixteen weeks pregnant, but it is acceptable to obtain a blood sample as late as nineteen weeks. 7 An abnormally high AFP test score indicates that the fetus may have spina bifida, open spinal cord congenital abnormalities, or certain other serious potential problems. An abnormally low score is associated with Down’s Syndrome.

Even if an AFP test shows an increased risk of Down’s Syndrome or other serious potential problems, the test is not definitive—it merely shows a potential problem. To find out *645 for certain whether a fetus is afflicted with certain genetic problems, the mother must undergo an amniocentesis, a test whereby a physician, with the assistance of an ultrasound machine, extracts genetic material from the fluid in the sac surrounding the fetus. The material extracted is sent to a laboratory that grows the cells contained in the fluid in order to obtain a genetic profile. Once the results of an amniocentesis is known, the mother must consider the test results and, assuming there is still time for an abortion, decide whether she wants to abort the pregnancy. The parties agreed at trial that if an amniocentesis had been performed in this case it would have shown that the fetus Mrs. Kassama was carrying had Down’s Syndrome.

In Roe v. Wade, 410 U.S. 113, 125, 93 S.Ct. 705, 35 L.Ed.2d 147 (1973), Judge Blackman noted that the normal term of human pregnancy is 266 days (38 weeks). When Roe was decided, it was believed that a fetus was viable 8 “at about seven months (28 weeks) but [that viability] may occur earlier, even at 24 weeks.” Id. at 160, 93 S.Ct. 705. (Citing L. Heilman & J. Pritchard, Williams Obstetrics 493 (14th ed.1971)). More recently, in Planned Parenthood v. Casey, 505 *646 U.S. 833, 112 S.Ct. 2791, 120 L.Ed.2d 674 (1992), Justice O’Connor observed that viability sometimes occurs as early as twenty-three weeks. 9 Id. at 860, 112 S.Ct. 2791.

IV. MARYLAND’S ABORTION LAWS

There is no statutory time limitation in Maryland after which a genetically defective fetus or one suffering from a “serious deformity or abnormality” may not be terminated. In this regard, section 20-209(b) of the Health General article of the Annotated Code of Maryland (2000 Repl.Vol.) reads:

(b) State Intervention.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Reid v. Balt. Ambulatory Center
Court of Special Appeals of Maryland, 2026
Hawkins v. Barakat
D. Maryland, 2022
Konig v. WasteQuip, LLC
D. Maryland, 2021
Thibodeaux v. Sterling
D. Maryland, 2020
Barbosa v. Osbourne
183 A.3d 785 (Court of Special Appeals of Maryland, 2018)
Warsham v. James Muscatello, Inc.
985 A.2d 156 (Court of Special Appeals of Maryland, 2009)
Waterman v. Batton
294 F. Supp. 2d 709 (D. Maryland, 2003)
Dehn v. Edgecombe
834 A.2d 146 (Court of Special Appeals of Maryland, 2003)
Kassama v. Magat
792 A.2d 1102 (Court of Appeals of Maryland, 2002)
Prudential Securities Inc. v. E-Net, Inc.
780 A.2d 359 (Court of Special Appeals of Maryland, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
767 A.2d 348, 136 Md. App. 637, 2001 Md. App. LEXIS 24, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kassama-v-magat-mdctspecapp-2001.